Fig. 3From: European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 updateForest plots of comparison: 1 Monoclonal antibodies vs placebo - Episodic migraineBack to article page